0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Hemostats Market Report & Forecast 2023-2029
Published Date: November 2023
|
Report Code: QYRE-Auto-38A15666
Home | Market Reports | Health| Medical Devices & Equipment
Global and India Hemostats Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Hemostats Market Report & Forecast 2023-2029

Code: QYRE-Auto-38A15666
Report
November 2023
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

and India Hemostats Market Size

The global Hemostats revenue was US$ 2745.5 million in 2022 and is forecast to a readjusted size of US$ 4120.4 million by 2029 with a CAGR of 5.9% during the forecast period (2023-2029).

and India Hemostats Market

and India Hemostats Market

Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
In India, the Hemostats revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
Global Hemostats key players include Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard, The Medicines Company, etc. Global top five manufacturers hold a share over 55%.
North America is the largest market, with a share about 35%, followed by China, and Europe, both have a share over 35 percent.
In terms of product, Thrombin-Based Hemostats is the largest segment, with a share over 40%. And in terms of application, the largest application is Hospital Treatment, followed by Prehospital Treatment, etc.
This report focuses on global and India Hemostats market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Hemostats will continue to grow rapidly in the future.
Global Hemostats Scope and Market Size
Hemostats market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Hemostats market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Hemostats market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Hemostats Market Report

Report Metric Details
Report Name and India Hemostats Market
Forecasted market size in 2029 US$ 4120.4 million
CAGR 5.9%
Forecasted years 2023 - 2029
Segment by Type
  • Thrombin-Based Hemostats
  • Oxidized Regenerated Cellulose Based Hemostats
  • Combination Hemostats
  • Gelatin Based Hemostats
  • Collagen Based Hemostats
Segment by Application
  • Prehospital Treatment
  • Hospital Treatment
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Ethicon, Pfizer, Baxter International Inc., C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences Corporation, B Braun Melsungen AG, Gelita Medical GmbH, Equimedical, Vascular Solutions, Marine Polymer Technologies, Z-Medica, LLC, CryoLife, BioCer Entwicklungs-GmbH., Biom'Up SAS
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Hemostats Market size in 2029?

Ans: The and India Hemostats Market size in 2029 will be US$ 4120.4 million.

What is the market share of major companies in and India Hemostats Market?

Ans: Global top five manufacturers hold a share over 55%.

What is the and India Hemostats Market share by type?

Ans: In terms of product, Thrombin-Based Hemostats is the largest segment, with a share over 40%.

What is the and India Hemostats Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Hemostats Market report?

Ans: The main players in the and India Hemostats Market are Ethicon, Pfizer, Baxter International Inc., C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences Corporation, B Braun Melsungen AG, Gelita Medical GmbH, Equimedical, Vascular Solutions, Marine Polymer Technologies, Z-Medica, LLC, CryoLife, BioCer Entwicklungs-GmbH., Biom'Up SAS

What are the Application segmentation covered in the and India Hemostats Market report?

Ans: The Applications covered in the and India Hemostats Market report are Prehospital Treatment, Hospital Treatment

What are the Type segmentation covered in the and India Hemostats Market report?

Ans: The Types covered in the and India Hemostats Market report are Thrombin-Based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, Collagen Based Hemostats

1 Study Coverage
1.1 Hemostats Product Introduction
1.2 Global Hemostats Outlook 2018 VS 2022 VS 2029
1.2.1 Global Hemostats Sales in US$ Million for the Year 2018-2029
1.2.2 Global Hemostats Sales in Volume for the Year 2018-2029
1.3 India Hemostats Outlook 2018 VS 2022 VS 2029
1.3.1 India Hemostats Sales in US$ Million for the Year 2018-2029
1.3.2 India Hemostats Sales in Volume for the Year 2018-2029
1.4 Hemostats Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of India Hemostats in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of Hemostats Market Size, India VS Global, 2018 VS 2022 VS 2029
1.5 Hemostats Market Dynamics
1.5.1 Hemostats Industry Trends
1.5.2 Hemostats Market Drivers
1.5.3 Hemostats Market Challenges
1.5.4 Hemostats Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Hemostats by Type
2.1 Hemostats Market Segment by Type
2.1.1 Thrombin-Based Hemostats
2.1.2 Oxidized Regenerated Cellulose Based Hemostats
2.1.3 Combination Hemostats
2.1.4 Gelatin Based Hemostats
2.1.5 Collagen Based Hemostats
2.2 Global Hemostats Market Size by Type
2.2.1 Global Hemostats Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global Hemostats Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global Hemostats Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 India Hemostats Market Size by Type
2.3.1 India Hemostats Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 India Hemostats Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 India Hemostats Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 Hemostats by Application
3.1 Hemostats Market Segment by Application
3.1.1 Prehospital Treatment
3.1.2 Hospital Treatment
3.2 Global Hemostats Market Size by Application
3.2.1 Global Hemostats Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global Hemostats Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global Hemostats Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 India Hemostats Market Size by Application
3.3.1 India Hemostats Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 India Hemostats Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 India Hemostats Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global Hemostats Competitor Landscape by Company
4.1 Global Hemostats Market Size by Company
4.1.1 Global Key Manufacturers of Hemostats, Ranked by Revenue (2022)
4.1.2 Global Hemostats Revenue by Manufacturer (2018-2023)
4.1.3 Global Hemostats Sales by Manufacturer (2018-2023)
4.1.4 Global Hemostats Price by Manufacturer (2018-2023)
4.2 Global Hemostats Concentration Ratio (CR)
4.2.1 Hemostats Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Hemostats in 2022
4.2.3 Global Hemostats Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Hemostats, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Hemostats, Product Offered and Application
4.5 Global Key Manufacturers of Hemostats, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Hemostats Market Size by Company
4.7.1 Key Players of Hemostats in India, Ranked by Revenue (2022)
4.7.2 India Hemostats Revenue by Players (2018-2023)
4.7.3 India Hemostats Sales by Players (2018-2023)
5 Global Hemostats Market Size by Region
5.1 Global Hemostats Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Hemostats Market Size in Volume by Region (2018-2029)
5.2.1 Global Hemostats Sales in Volume by Region: 2018-2023
5.2.2 Global Hemostats Sales in Volume Forecast by Region (2024-2029)
5.3 Global Hemostats Market Size in Value by Region (2018-2029)
5.3.1 Global Hemostats Sales in Value by Region: 2018-2023
5.3.2 Global Hemostats Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas Hemostats Market Size YoY Growth 2018-2029
6.2 Americas Hemostats Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas Hemostats Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas Hemostats Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas Hemostats Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas Hemostats Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Hemostats Market Size YoY Growth 2018-2029
7.2 EMEA Hemostats Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA Hemostats Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA Hemostats Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA Hemostats Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA Hemostats Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Hemostats Market Size YoY Growth 2018-2029
8.2 China Hemostats Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China Hemostats Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC Hemostats Market Size YoY Growth 2018-2029
9.2 APAC Hemostats Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC Hemostats Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC Hemostats Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC Hemostats Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC Hemostats Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Ethicon
10.1.1 Ethicon Company Information
10.1.2 Ethicon Description and Business Overview
10.1.3 Ethicon Hemostats Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Ethicon Hemostats Products Offered
10.1.5 Ethicon Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Description and Business Overview
10.2.3 Pfizer Hemostats Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Pfizer Hemostats Products Offered
10.2.5 Pfizer Recent Development
10.3 Baxter International Inc.
10.3.1 Baxter International Inc. Company Information
10.3.2 Baxter International Inc. Description and Business Overview
10.3.3 Baxter International Inc. Hemostats Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Baxter International Inc. Hemostats Products Offered
10.3.5 Baxter International Inc. Recent Development
10.4 C. R. Bard
10.4.1 C. R. Bard Company Information
10.4.2 C. R. Bard Description and Business Overview
10.4.3 C. R. Bard Hemostats Sales, Revenue and Gross Margin (2018-2023)
10.4.4 C. R. Bard Hemostats Products Offered
10.4.5 C. R. Bard Recent Development
10.5 The Medicines Company
10.5.1 The Medicines Company Company Information
10.5.2 The Medicines Company Description and Business Overview
10.5.3 The Medicines Company Hemostats Sales, Revenue and Gross Margin (2018-2023)
10.5.4 The Medicines Company Hemostats Products Offered
10.5.5 The Medicines Company Recent Development
10.6 Anika Therapeutics
10.6.1 Anika Therapeutics Company Information
10.6.2 Anika Therapeutics Description and Business Overview
10.6.3 Anika Therapeutics Hemostats Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Anika Therapeutics Hemostats Products Offered
10.6.5 Anika Therapeutics Recent Development
10.7 Advanced Medical Solutions
10.7.1 Advanced Medical Solutions Company Information
10.7.2 Advanced Medical Solutions Description and Business Overview
10.7.3 Advanced Medical Solutions Hemostats Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Advanced Medical Solutions Hemostats Products Offered
10.7.5 Advanced Medical Solutions Recent Development
10.8 Integra LifeSciences Corporation
10.8.1 Integra LifeSciences Corporation Company Information
10.8.2 Integra LifeSciences Corporation Description and Business Overview
10.8.3 Integra LifeSciences Corporation Hemostats Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Integra LifeSciences Corporation Hemostats Products Offered
10.8.5 Integra LifeSciences Corporation Recent Development
10.9 B Braun Melsungen AG
10.9.1 B Braun Melsungen AG Company Information
10.9.2 B Braun Melsungen AG Description and Business Overview
10.9.3 B Braun Melsungen AG Hemostats Sales, Revenue and Gross Margin (2018-2023)
10.9.4 B Braun Melsungen AG Hemostats Products Offered
10.9.5 B Braun Melsungen AG Recent Development
10.10 Gelita Medical GmbH
10.10.1 Gelita Medical GmbH Company Information
10.10.2 Gelita Medical GmbH Description and Business Overview
10.10.3 Gelita Medical GmbH Hemostats Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Gelita Medical GmbH Hemostats Products Offered
10.10.5 Gelita Medical GmbH Recent Development
10.11 Equimedical
10.11.1 Equimedical Company Information
10.11.2 Equimedical Description and Business Overview
10.11.3 Equimedical Hemostats Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Equimedical Hemostats Products Offered
10.11.5 Equimedical Recent Development
10.12 Vascular Solutions
10.12.1 Vascular Solutions Company Information
10.12.2 Vascular Solutions Description and Business Overview
10.12.3 Vascular Solutions Hemostats Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Vascular Solutions Hemostats Products Offered
10.12.5 Vascular Solutions Recent Development
10.13 Marine Polymer Technologies
10.13.1 Marine Polymer Technologies Company Information
10.13.2 Marine Polymer Technologies Description and Business Overview
10.13.3 Marine Polymer Technologies Hemostats Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Marine Polymer Technologies Hemostats Products Offered
10.13.5 Marine Polymer Technologies Recent Development
10.14 Z-Medica, LLC
10.14.1 Z-Medica, LLC Company Information
10.14.2 Z-Medica, LLC Description and Business Overview
10.14.3 Z-Medica, LLC Hemostats Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Z-Medica, LLC Hemostats Products Offered
10.14.5 Z-Medica, LLC Recent Development
10.15 CryoLife
10.15.1 CryoLife Company Information
10.15.2 CryoLife Description and Business Overview
10.15.3 CryoLife Hemostats Sales, Revenue and Gross Margin (2018-2023)
10.15.4 CryoLife Hemostats Products Offered
10.15.5 CryoLife Recent Development
10.16 BioCer Entwicklungs-GmbH.
10.16.1 BioCer Entwicklungs-GmbH. Company Information
10.16.2 BioCer Entwicklungs-GmbH. Description and Business Overview
10.16.3 BioCer Entwicklungs-GmbH. Hemostats Sales, Revenue and Gross Margin (2018-2023)
10.16.4 BioCer Entwicklungs-GmbH. Hemostats Products Offered
10.16.5 BioCer Entwicklungs-GmbH. Recent Development
10.17 Biom'Up SAS
10.17.1 Biom'Up SAS Company Information
10.17.2 Biom'Up SAS Description and Business Overview
10.17.3 Biom'Up SAS Hemostats Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Biom'Up SAS Hemostats Products Offered
10.17.5 Biom'Up SAS Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Hemostats Industry Chain Analysis
11.2 Hemostats Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Hemostats Production Mode & Process
11.4 Hemostats Sales and Marketing
11.4.1 Hemostats Sales Channels
11.4.2 Hemostats Distributors
11.5 Hemostats Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Hemostats CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
    Table 2. Hemostats Market Trends
    Table 3. Hemostats Market Drivers
    Table 4. Hemostats Market Challenges
    Table 5. Hemostats Market Restraints
    Table 6. Global Hemostats Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Hemostats Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Hemostats Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Hemostats Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Manufacturers of Hemostats, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Hemostats Revenue by Manufacturer, (US$ Million), 2018-2023
    Table 12. Global Hemostats Revenue Share by Manufacturer, 2018-2023
    Table 13. Global Hemostats Sales by Manufacturer, (K Pcs), 2018-2023
    Table 14. Global Hemostats Sales Share by Manufacturer, 2018-2023
    Table 15. Global Hemostats Price by Manufacturer (2018-2023) & (USD/Pcs)
    Table 16. Global Hemostats Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Hemostats by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostats as of 2022)
    Table 18. Global Key Manufacturers of Hemostats, Manufacturing Base Distribution and Headquarters
    Table 19. Global Key Manufacturers of Hemostats, Product Offered and Application
    Table 20. Global Key Manufacturers of Hemostats, Date of Enter into This Industry
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Key Players of Hemostats in India, Ranked by Revenue (2022) & (US$ million)
    Table 23. India Hemostats Revenue by Players, (US$ Million), (2018-2023)
    Table 24. India Hemostats Revenue Share by Players, (2018-2023)
    Table 25. India Hemostats Sales by Players, (K Pcs), (2018-2023)
    Table 26. India Hemostats Sales Share by Players, (2018-2023)
    Table 27. Global Hemostats Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 28. Global Hemostats Sales in Volume by Region (2018-2023) & (K Pcs)
    Table 29. Global Hemostats Sales in Volume Forecast by Region (2024-2029) & (K Pcs)
    Table 30. Global Hemostats Sales in Value by Region (2018-2023) & (US$ Million)
    Table 31. Global Hemostats Sales in Value Forecast by Region (2024-2029) & (US$ Million)
    Table 32. Americas Hemostats Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. Americas Hemostats Sales in Value by Country (2018-2023) & (US$ Million)
    Table 34. Americas Hemostats Sales in Value by Country (2024-2029) & (US$ Million)
    Table 35. Americas Hemostats Sales in Volume by Country (2018-2023) & (K Pcs)
    Table 36. Americas Hemostats Sales in Volume by Country (2024-2029) & (K Pcs)
    Table 37. EMEA Hemostats Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. EMEA Hemostats Sales in Value by Country (2018-2023) & (US$ Million)
    Table 39. EMEA Hemostats Sales in Value by Country (2024-2029) & (US$ Million)
    Table 40. EMEA Hemostats Sales in Volume by Country (2018-2023) & (K Pcs)
    Table 41. EMEA Hemostats Sales in Volume by Country (2024-2029) & (K Pcs)
    Table 42. APAC Hemostats Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. APAC Hemostats Sales in Value by Country (2018-2023) & (US$ Million)
    Table 44. APAC Hemostats Sales in Value by Country (2024-2029) & (US$ Million)
    Table 45. APAC Hemostats Sales in Volume by Country (2018-2023) & (K Pcs)
    Table 46. APAC Hemostats Sales in Volume by Country (2024-2029) & (K Pcs)
    Table 47. Ethicon Company Information
    Table 48. Ethicon Description and Business Overview
    Table 49. Ethicon Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 50. Ethicon Hemostats Product
    Table 51. Ethicon Recent Development
    Table 52. Pfizer Company Information
    Table 53. Pfizer Description and Business Overview
    Table 54. Pfizer Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 55. Pfizer Hemostats Product
    Table 56. Pfizer Recent Development
    Table 57. Baxter International Inc. Company Information
    Table 58. Baxter International Inc. Description and Business Overview
    Table 59. Baxter International Inc. Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 60. Baxter International Inc. Hemostats Product
    Table 61. Baxter International Inc. Recent Development
    Table 62. C. R. Bard Company Information
    Table 63. C. R. Bard Description and Business Overview
    Table 64. C. R. Bard Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 65. C. R. Bard Hemostats Product
    Table 66. C. R. Bard Recent Development
    Table 67. The Medicines Company Company Information
    Table 68. The Medicines Company Description and Business Overview
    Table 69. The Medicines Company Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 70. The Medicines Company Hemostats Product
    Table 71. The Medicines Company Recent Development
    Table 72. Anika Therapeutics Company Information
    Table 73. Anika Therapeutics Description and Business Overview
    Table 74. Anika Therapeutics Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 75. Anika Therapeutics Hemostats Product
    Table 76. Anika Therapeutics Recent Development
    Table 77. Advanced Medical Solutions Company Information
    Table 78. Advanced Medical Solutions Description and Business Overview
    Table 79. Advanced Medical Solutions Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 80. Advanced Medical Solutions Hemostats Product
    Table 81. Advanced Medical Solutions Recent Development
    Table 82. Integra LifeSciences Corporation Company Information
    Table 83. Integra LifeSciences Corporation Description and Business Overview
    Table 84. Integra LifeSciences Corporation Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 85. Integra LifeSciences Corporation Hemostats Product
    Table 86. Integra LifeSciences Corporation Recent Development
    Table 87. B Braun Melsungen AG Company Information
    Table 88. B Braun Melsungen AG Description and Business Overview
    Table 89. B Braun Melsungen AG Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 90. B Braun Melsungen AG Hemostats Product
    Table 91. B Braun Melsungen AG Recent Development
    Table 92. Gelita Medical GmbH Company Information
    Table 93. Gelita Medical GmbH Description and Business Overview
    Table 94. Gelita Medical GmbH Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 95. Gelita Medical GmbH Hemostats Product
    Table 96. Gelita Medical GmbH Recent Development
    Table 97. Equimedical Company Information
    Table 98. Equimedical Description and Business Overview
    Table 99. Equimedical Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 100. Equimedical Hemostats Product
    Table 101. Equimedical Recent Development
    Table 102. Vascular Solutions Company Information
    Table 103. Vascular Solutions Description and Business Overview
    Table 104. Vascular Solutions Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 105. Vascular Solutions Hemostats Product
    Table 106. Vascular Solutions Recent Development
    Table 107. Marine Polymer Technologies Company Information
    Table 108. Marine Polymer Technologies Description and Business Overview
    Table 109. Marine Polymer Technologies Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 110. Marine Polymer Technologies Hemostats Product
    Table 111. Marine Polymer Technologies Recent Development
    Table 112. Z-Medica, LLC Company Information
    Table 113. Z-Medica, LLC Description and Business Overview
    Table 114. Z-Medica, LLC Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 115. Z-Medica, LLC Hemostats Product
    Table 116. Z-Medica, LLC Recent Development
    Table 117. CryoLife Company Information
    Table 118. CryoLife Description and Business Overview
    Table 119. CryoLife Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 120. CryoLife Hemostats Product
    Table 121. CryoLife Recent Development
    Table 122. BioCer Entwicklungs-GmbH. Company Information
    Table 123. BioCer Entwicklungs-GmbH. Description and Business Overview
    Table 124. BioCer Entwicklungs-GmbH. Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 125. BioCer Entwicklungs-GmbH. Hemostats Product
    Table 126. BioCer Entwicklungs-GmbH. Recent Development
    Table 127. Biom'Up SAS Company Information
    Table 128. Biom'Up SAS Description and Business Overview
    Table 129. Biom'Up SAS Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 130. Biom'Up SAS Hemostats Product
    Table 131. Biom'Up SAS Recent Development
    Table 132. Key Raw Materials Lists
    Table 133. Raw Materials Key Suppliers Lists
    Table 134. Hemostats Customers List
    Table 135. Hemostats Distributors List
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Hemostats Product Picture
    Figure 2. Global Hemostats Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Hemostats Market Size 2018-2029 (US$ Million)
    Figure 4. Global Hemostats Sales 2018-2029 (K Pcs)
    Figure 5. India Hemostats Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 6. India Hemostats Market Size 2018-2029 (US$ Million)
    Figure 7. India Hemostats Sales 2018-2029 (K Pcs)
    Figure 8. India Hemostats Market Share in Global, in Value (US$ Million) 2018-2029
    Figure 9. India Hemostats Market Share in Global, in Volume (K Pcs) 2018-2029
    Figure 10. Hemostats Report Years Considered
    Figure 11. Product Picture of Thrombin-Based Hemostats
    Figure 12. Product Picture of Oxidized Regenerated Cellulose Based Hemostats
    Figure 13. Product Picture of Combination Hemostats
    Figure 14. Product Picture of Gelatin Based Hemostats
    Figure 15. Product Picture of Collagen Based Hemostats
    Figure 16. Global Hemostats Market Share by Type in 2022 & 2029
    Figure 17. Global Hemostats Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 18. Global Hemostats Sales Market Share in Value by Type (2018-2029)
    Figure 19. Global Hemostats Sales by Type (2018-2029) & (K Pcs)
    Figure 20. Global Hemostats Sales Market Share in Volume by Type (2018-2029)
    Figure 21. Global Hemostats Price by Type (2018-2029) & (USD/Pcs)
    Figure 22. India Hemostats Market Share by Type in 2022 & 2029
    Figure 23. India Hemostats Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 24. India Hemostats Sales Market Share in Value by Type (2018-2029)
    Figure 25. India Hemostats Sales by Type (2018-2029) & (K Pcs)
    Figure 26. India Hemostats Sales Market Share in Volume by Type (2018-2029)
    Figure 27. India Hemostats Price by Type (2018-2029) & (USD/Pcs)
    Figure 28. Product Picture of Prehospital Treatment
    Figure 29. Product Picture of Hospital Treatment
    Figure 30. Global Hemostats Market Share by Application in 2022 & 2029
    Figure 31. Global Hemostats Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 32. Global Hemostats Sales Market Share in Value by Application (2018-2029)
    Figure 33. Global Hemostats Sales by Application (2018-2029) & (K Pcs)
    Figure 34. Global Hemostats Sales Market Share in Volume by Application (2018-2029)
    Figure 35. Global Hemostats Price by Application (2018-2029) & (USD/Pcs)
    Figure 36. India Hemostats Market Share by Application in 2022 & 2029
    Figure 37. India Hemostats Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 38. India Hemostats Sales Market Share in Value by Application (2018-2029)
    Figure 39. India Hemostats Sales by Application (2018-2029) & (K Pcs)
    Figure 40. India Hemostats Sales Market Share in Volume by Application (2018-2029)
    Figure 41. India Hemostats Price by Application (2018-2029) & (USD/Pcs)
    Figure 42. Americas Hemostats Sales in Volume Growth Rate 2018-2029 (K Pcs)
    Figure 43. Americas Hemostats Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 44. Americas Hemostats Sales by Type (2018-2029) & (K Pcs)
    Figure 45. Americas Hemostats Sales Market Share in Volume by Type (2018-2029)
    Figure 46. Americas Hemostats Sales by Application (2018-2029) & (K Pcs)
    Figure 47. Americas Hemostats Sales Market Share in Volume by Application (2018-2029)
    Figure 48. United States Hemostats Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Canada Hemostats Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Mexico Hemostats Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Brazil Hemostats Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 52. EMEA Hemostats Sales in Volume Growth Rate 2018-2029 (K Pcs)
    Figure 53. EMEA Hemostats Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 54. EMEA Hemostats Sales by Type (2018-2029) & (K Pcs)
    Figure 55. EMEA Hemostats Sales Market Share in Volume by Type (2018-2029)
    Figure 56. EMEA Hemostats Sales by Application (2018-2029) & (K Pcs)
    Figure 57. EMEA Hemostats Sales Market Share in Volume by Application (2018-2029)
    Figure 58. Europe Hemostats Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 59. Middle East Hemostats Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 60. Africa Hemostats Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 61. China Hemostats Sales in Volume Growth Rate 2018-2029 (K Pcs)
    Figure 62. China Hemostats Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 63. China Hemostats Sales by Type (2018-2029) & (K Pcs)
    Figure 64. China Hemostats Sales Market Share in Volume by Type (2018-2029)
    Figure 65. China Hemostats Sales by Application (2018-2029) & (K Pcs)
    Figure 66. China Hemostats Sales Market Share in Volume by Application (2018-2029)
    Figure 67. APAC Hemostats Sales in Volume Growth Rate 2018-2029 (K Pcs)
    Figure 68. APAC Hemostats Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 69. APAC Hemostats Sales by Type (2018-2029) & (K Pcs)
    Figure 70. APAC Hemostats Sales Market Share in Volume by Type (2018-2029)
    Figure 71. APAC Hemostats Sales by Application (2018-2029) & (K Pcs)
    Figure 72. APAC Hemostats Sales Market Share in Volume by Application (2018-2029)
    Figure 73. Japan Hemostats Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 74. South Korea Hemostats Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 75. China Taiwan Hemostats Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 76. Southeast Asia Hemostats Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 77. India Hemostats Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 78. Hemostats Value Chain
    Figure 79. Hemostats Production Process
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37F12574
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15J20209
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8O12834
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adult Nasogastric Feeding Tube Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36J12622
Wed Dec 03 00:00:00 UTC 2025

Add to Cart